Kamada (KMDA) Assets Average (2013 - 2026)

Kamada (KMDA) posted quarterly Assets Average of $380.9 million for Q1 2026, up 1.92% year-on-year from $373.7 million in Q1 2025, and up 0.77% on a QoQ basis from $378.0 million in Q4 2025.

Kamada (KMDA) Assets Average (2013 - 2026) Analysis & Trends

Kamada (KMDA) has reported Assets Average for 11 consecutive years, with $380.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Assets Average rose 1.92% year-over-year to $380.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $380.9 million (up 1.92% YoY) and the FY2025 annual result came in at $375.5 million, down 99.79% from the prior year.
  • Assets Average climbed to $380.9 million in Q1 2026 per KMDA's latest filing, from $378.0 million in the prior quarter.
  • Over the last five years, Assets Average for KMDA reached as high as $346.0 billion in Q4 2023 and fell as low as $303.6 million in Q2 2022.
  • A 5-year average of $41.0 billion and a median of $361.7 million in 2024 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2023 — Assets Average jumped 107679.71% — and 2024, when it sank 99.9%.
  • Year by year, Assets Average stood at $321.0 million in 2022, then soared by 107679.71% to $346.0 billion in 2023, then plunged by 99.9% to $361.7 million in 2024, then gained by 4.49% to $378.0 million in 2025, then climbed by 0.77% to $380.9 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $380.9 million, $378.0 million, and $372.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.72 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.32 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 99.52 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 7.30 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 68.63 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 37.01 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.77 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.29 Bn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 380.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 380.87 Mn
Dec 31, 2025 377.96 Mn
Sep 30, 2025 372.69 Mn
Jun 30, 2025 371.64 Mn
Mar 31, 2025 373.68 Mn
Dec 31, 2024 361.73 Mn
Sep 30, 2024 351.12 Mn
Jun 30, 2024 347.11 Mn
Mar 31, 2024 177.63 Bn
Dec 31, 2023 345.98 Bn
Sep 30, 2023 168.69 Bn
Jun 30, 2023 315.59 Mn
Mar 31, 2023 319.59 Mn
Dec 31, 2022 321.01 Mn
Sep 30, 2022 311.89 Mn
Jun 30, 2022 303.62 Mn
Mar 31, 2022 310.88 Mn
Dec 31, 2021 267.60 Mn
Sep 30, 2021 216.44 Mn
Jun 30, 2021 213.44 Mn